173
Participants
Start Date
May 26, 2017
Primary Completion Date
September 16, 2020
Study Completion Date
July 26, 2021
Cisplatin
Cisplatin 25 mg/m2 IV administered on day 1 and day 8 of 21 day cycle, for up to maximum 6 cycles
Gemcitabine
Gemcitabine 1000 mg/m2 IV administered on days 1 and 8 of a 21-day cycle
Anetumab ravtansine (BAY94-9343)
Anetumab ravtansine 6.5mg/kg IV in monotherapy indications. For combination indications, the MTD determined in safety lead in phase will be administered
Hôpital Erasme/Erasmus Ziekenhuis, Bruxelles - Brussel
Kinghorn Cancer Centre, Darlinghurst
Northern Cancer Institute, St Leonards
Blacktown Cancer & Haematology Centre, Blacktown
Mid North Coast Cancer Institute, Coffs Harbour
UZ Antwerpen, Edegem
UZ Leuven Gasthuisberg, Leuven
Epworth HealthCare, Richmond
CHU de Liège, Liège
Flinders Medical Centre, Adelaide
St John of God Healthcare, Subiaco
Sir Charles Gairdner Hospital, Nedlands
Ospedale Regionale Bellinzona, Bellinzona
Kantonsspital Graubünden, Chur
C.H.U. Timone, Marseille
MedStar Georgetown University Hospital, Washington D.C.
Istituto Clinico Humanitas - Humanitas Mirasole S.p.A., Milan
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
ASST Grande Ospedale Metropolitano Niguarda, Milan
National Cancer Institute - Maryland, Bethesda
Hopital Jean Minjoz, Besançon
Hospital Universitario 12 de Octubre, Madrid
Centro Integral Oncológico Clara Campal, Madrid
Hospital Universitario Quirón de Madrid, Pozuelo de Alarcón
Hospital Virgen de la Victoria, Málaga
Hôpital Pontchaillou, Rennes
Centre Eugène Marquis - Rennes Cedex, Rennes
A.O.U.I. Verona, Verona
Vanderbilt University Medical Center, Nashville
A.O.U. di Bologna Policlinico S.Orsola Malpighi, Bologna
A.O.U. di Modena - Policlinico, Modena
Centre René Gauducheau, Nantes
Indiana University School of Medicine, Indianapolis
Barbara Ann Karmanos Cancer Institute, Farmington Hills
Mayo Clinic - Rochester, Rochester
Centre Oscar Lambret - Lille, Lille
Washington University School of Medicine, St Louis
Centre Léon Bérard, Lyon
Centre Hospitalier Lyon Sud, Pierre-Bénite
Ochsner Medical Center - New Orleans, New Orleans
Texas Oncology, PA, Dallas
University of Texas MD Anderson Cancer Center, Houston
Hôpital de la Milétrie, Poitiers
University of Southern California, Los Angeles
Hôpital Henri Mondor, Créteil
Stanford Health Care, Stanford
Institut Gustave Roussy, Villejuif
National University Hospital, Singapore
National Cancer Center Singapore, Singapore
Mayo Clinic Hospital, Phoenix
Cross Cancer Institute, Edmonton
Princess Margaret Cancer Centre - UHN, Toronto
Sir Mortimer B. Davis Jewish General Hospital, Montreal
McGill University Health Center, Montreal
Centre Antoine Lacassagne, Nice
Nederlands Kanker Instituut, Amsterdam
Maastricht UMC, Maastricht
Seoul National University Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Hospital del Mar, Barcelona
Ciutat Sanitària i Universitaria de la Vall d'Hebron, Barcelona
Hospital Clínic i Provincial de Barcelona, Barcelona
"Hospital General Universitario Gregorio Marañón , Oncología"
"Hospital Ramón y Cajal , Oncología"
Leicester Royal Infirmary, Leicester
Belfast City Hospital, Belfast
Royal Marsden NHS Trust (Surrey), Sutton
Guy's Hospital, London
Royal Marsden Hospital (London), London
Christie Hospital, Manchester
Lead Sponsor
Collaborators (2)
ImmunoGen, Inc.
INDUSTRY
MorphoSys AG
INDUSTRY
Bayer
INDUSTRY